ALDH2 attenuates radiation-induced lung injury by inhibiting ROS and epithelial-mesenchymal transition mediated by the TGF-β1/Smad pathway
Open Access
- 26 November 2024
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 87, 102334
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathwayEuropean Journal of Pharmacology, 2023
- METTL3 Mediates Epithelial–Mesenchymal Transition by Modulating FOXO1 mRNA N6‐Methyladenosine‐Dependent YTHDF2 Binding: A Novel Mechanism of Radiation‐Induced Lung InjuryAdvanced Science, 2023
- Acetaldehyde dehydrogenase 2 activation attenuates sepsis-induced brain injury through NLRP3 inflammasome regulationBrain Research Bulletin, 2023
- The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseasesCellular Signalling, 2022
- Advances in pathogenic mechanisms and management of radiation-induced fibrosisBiomedicine & Pharmacotherapy, 2020
- Radiation-Induced Lung InjuryChest, 2019
- The role of antioxidants in the chemistry of oxidative stress: A reviewEuropean Journal of Medicinal Chemistry, 2015
- An Experimental Model-Based Exploration of Cytokines in Ablative Radiation-Induced Lung Injury In Vivo and In VitroLung, 2015
- Free radicals, reactive oxygen species, oxidative stress and its classificationChemico-Biological Interactions, 2014
- Influence of acute and fractional X-irradiation on induction of interferon in vivoArchives of Virology, 1972